Please login to the form below
drug treatment
This page shows the latest drug treatment news and features for those working in and with pharma, biotech and healthcare.
Regeneron’s COVID-19 drug boosts survival in hospitalised patients lacking antibodies
The researchers noted that there was a clear difference in the effect of the treatment in seronegative patients compared to seropositive patients. ... REGEN-COV is currently available in the US under an emergency use authorisation (EUA) issued by the
Latest news
-
Biogen to begin shipping newly approved Alzheimer’s treatment in two weeks
Earlier this week, the US Food and Drug Administration (FDA) approved Aduhelm for the treatment of Alzheimer’s disease following months of controversy surrounding the drug. ... Biogen’s drug is the first treatment approved by the FDA that targets the
-
Merck signs $1.2bn supply deal with US government for Molnupiravir
The deal, worth $1.2bn, is contingent upon the US Food and Drug Administration (FDA) issuing an Emergency Use Authorization (EUA) or approval for the treatment. ... Merck expects to have more than ten million courses of the treatment available by the end
-
FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
Biogen’s aducanumab has been approved by the US Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease, in a landmark moment for the therapy area. ... If Aduhelm fails to prove its clinical benefit for patients, the FDA can
-
J&J exits $1.6bn blood cancer drug licensing deal with argenx
In December 2018, J&J and argenx signed a deal centred on cusatuzumab, to develop the drug for the treatment of acute myeloid leukaemia (AML), myelodysplastic syndrome (MDS) and other haematological ... The decision is based upon Janssen's review of all
-
BMS’ Zeposia gains FDA approval in ulcerative colitis
Treatment was initially approved in 2020 for multiple sclerosis. Bristol Myers Squibb’s S1P receptor modulator Zeposia has received US Food and Drug Administration (FDA) approval for the treatment of moderately ... Zeposia was initially approved by the
Biogen to begin shipping newly approved Alzheimer’s treatment in two weeks
Merck signs $1.2bn supply deal with US government for Molnupiravir
FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
J&J exits $1.6bn blood cancer drug licensing deal with argenx
BMS’ Zeposia gains FDA approval in ulcerative colitis
More from news
Approximately 1 fully matching, plus 940 partially matching documents found.
Latest Intelligence
-
The promise of precision medicine
treatment. The world- class Sidra Medicine hospital and the Qatar Biomedical Research Institute are using genomes to identify personalised lifestyle interventions to tackle obesity. ... of the right drug treatment for the individual.
-
Rare genetic diseases – what’s in store for 2021?
In 2021 we can expect more clinical studies that produce meaningful data, more advanced research and an increase in drug approvals that offer truly innovative treatment options. ... We’re looking at digital advances that would improve access to
-
The search for effective drug treatments for COVID-19
to find an effective drug treatment for patients and the journey of remdesivir that began a decade ago as part of Gilead’s emerging viruses programme. ... The World Health Organization (WHO) has not included Gilead’s antiviral treatment remdesivir in
-
Time to tear down the wallpaper?
treatment or breakthrough drug?
-
AI: the smart money is on the smart thinking
This influx of capital means there are already close to 200 start-ups using AI in drug discovery. ... Take, for example, the case of baricitinib, originally an Eli Lilly rheumatoid arthritis drug, now repurposed as a promising treatment for COVID-19.
The promise of precision medicine
Rare genetic diseases – what’s in store for 2021?
The search for effective drug treatments for COVID-19
Time to tear down the wallpaper?
AI: the smart money is on the smart thinking
More from intelligence
Approximately 0 fully matching, plus 50 partially matching documents found.
Latest appointments
-
Finland's Faron Pharmaceuticals appoints new medical director
In his new role he will join Turku-based Faron's executive management team and oversee its drug development strategy, including its clinical programmes for Traumakine and Clevegen. ... Our lead drug candidate Traumakine, for the treatment of Acute
-
Canbex hires former Lilly medical director
As chief medical officer at Canbex Dr Lledó will lead preparations for proof of concept trials for the company's lead candidate VSN16R, an oral drug intended for the treatment of ... As a practicing neurologist and experienced drug developer, I am very
Finland's Faron Pharmaceuticals appoints new medical director
Canbex hires former Lilly medical director
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide
The campaign shares their unique reasons for carrying naloxone, a drug that they now all carry. ... pharmacies and drug treatment centres, ensuring the lifesaving message reaches the people who need to see it.
-
How a design mindset can lead to better medical outcomes
When this starts earlier in the development process, it proves to be hugely beneficial in demonstrating the tangible value to the patient of the drug or treatment, the support structure surrounding ... Understanding the patient. Exactly how this
-
How to design better medical outcomes: Combining patient insights and empathetic design
When this starts earlier in the development process, it proves to be hugely beneficial in demonstrating the tangible value to the patient of the drug or treatment, the support structure surrounding ... Understanding the patient. Exactly how this
-
August 2020: diversity and inclusion in clinical trials round-up
The board certification process for healthcare providers should include an appropriate understanding of the clinical relevance of sex-differences in drug treatment. ... Pharmaceutical companies should pay more attention to sex-appropriate dosing,
-
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
Put simply, underrepresentation of anyone - male or female, old or young, and any ethnicities - means that researchers don’t actually know if the treatment or drug they’re investigating works for
THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide
August 2020: diversity and inclusion in clinical trials round-up
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
- Senior Account Director, Publications, Women’s health, Medical C...
-
Highly competitive salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer, Rare diseases, Medical Communications age...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Account Director, Publications, Opthalmology, Medical Communicat...
-
Highly competitive salary
- Senior Account Director, Publications, Opthalmology, Medical Com...
-
Highly competitive salary
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Senior Account Manager
-
Salary TBC
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
-
Planner
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Disappointing results from CureVac’s COVID-19 vaccine as phase 2/3 study shows only 47% efficacy
- Sanofi’s C1s inhibitor sutimlimab hits the mark in late-stage CAD study
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- Court rules on AZ and EU’s COVID-19 vaccine dispute
- BMS and Eisai to collaborate in deal worth up to $3.1bn
- US announces $3bn funding boost for antiviral COVID-19 treatments
- Biogen doses first patient in phase 3 systemic lupus erythematosus study
- Kite partners with Shoreline Biosciences to develop allogeneic cell therapies
- ‘Funny’, ha ha: how neurodiverse comedy can help us understand each other
No results were found
PMHub
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...
Latest intelligence
- How early-stage clinical research is facilitating the new wave of personalised medicines
- By Jorg Taubel...
- Patient diversity in clinical trials needs to be centre stage
- By Danny Buckland...
- Why empathy in digital patient recruitment is vital
- This is where empathy mapping can be incredibly effective....
